{"id":"W3085896652","doi":"10.1007/s11136-020-02623-1","title":"Changes in patient functioning and disability: results from a phase 3, double-blind, randomized, placebo-controlled clinical trial evaluating galcanezumab for chronic migraine prevention (REGAIN)","year":2020,"lang":"en","type":"article","venue":"Quality of Life Research","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"Eli Lilly and Company","keywords":"Placebo; Migraine; Medicine; Chronic Migraine; Internal medicine; Quality of life (healthcare); Repeated measures design; Gastroenterology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.03462937,0.0001989036,0.002152695,0.0001411037,0.0001757452,0.00004936149,0.000097784,0.0001777394,0.00006821927],"category_scores_gemma":[0.06100498,0.000155966,0.0005017148,0.0003364412,0.0005967956,0.0001139271,0.0001419062,0.0006184907,0.000003149154],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000144566,"about_ca_system_score_gemma":0.0006844592,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00129129,"about_ca_topic_score_gemma":0.003349819,"domain_scores_codex":[0.9910062,0.004244555,0.002420752,0.0007272664,0.00113832,0.0004629098],"domain_scores_gemma":[0.9796301,0.01853519,0.0005566679,0.0003730728,0.0005747522,0.0003301929],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9675807,0.001165265,0.0002695496,0.0005748057,0.0005138353,0.000001609185,0.005400243,0.00000401413,0.0002204615,0.00006149204,0.00102465,0.02318339],"study_design_scores_gemma":[0.9676734,0.01491065,0.0001624551,0.0004330859,0.0002015103,3.238369e-7,0.005362556,0.01023828,0.0000845703,0.0003260683,0.0004782425,0.0001289228],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9533532,0.003310611,0.0001674618,0.03040256,0.0000567772,0.01250728,0.00006415707,0.00002494497,0.000113063],"genre_scores_gemma":[0.9946349,0.0009518224,0.0005626209,0.0001806076,0.001490732,0.001685517,0.0002400778,0.00002001761,0.0002337034],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04128176,"threshold_uncertainty_score":0.9940522,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.6070549897591327,"score_gpt":0.5814425232642805,"score_spread":0.02561246649485227,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}